nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—ADRA2A—Signaling Pathways—VWF—atherosclerosis	0.000323	0.000323	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.000322	0.000322	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	0.000321	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	0.000319	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TGFB1—atherosclerosis	0.000319	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KNG1—atherosclerosis	0.000318	0.000318	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—HMOX1—atherosclerosis	0.000318	0.000318	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AGTR1—atherosclerosis	0.000316	0.000316	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	0.000315	0.000315	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.000313	0.000313	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	0.000312	0.000312	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PIK3CG—atherosclerosis	0.000311	0.000311	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CCL2—atherosclerosis	0.00031	0.00031	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PLG—atherosclerosis	0.000308	0.000308	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000308	0.000308	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—MAPK3—atherosclerosis	0.000307	0.000307	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOB—atherosclerosis	0.000304	0.000304	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000304	0.000304	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000304	0.000304	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000302	0.000302	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ABCA1—atherosclerosis	0.000301	0.000301	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.0003	0.0003	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	0.000299	0.000299	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TGFB1—atherosclerosis	0.000298	0.000298	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KNG1—atherosclerosis	0.000297	0.000297	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTM1—atherosclerosis	0.000296	0.000296	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000296	0.000296	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000296	0.000296	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000296	0.000296	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AGTR1—atherosclerosis	0.000295	0.000295	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SOCS3—atherosclerosis	0.000292	0.000292	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	0.000291	0.000291	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—LPL—atherosclerosis	0.000291	0.000291	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CCL2—atherosclerosis	0.00029	0.00029	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PLG—atherosclerosis	0.000288	0.000288	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	0.000286	0.000286	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.000284	0.000284	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GPX1—atherosclerosis	0.000284	0.000284	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	0.000282	0.000282	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	0.000282	0.000282	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP3—atherosclerosis	0.000282	0.000282	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	0.000281	0.000281	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF2—atherosclerosis	0.000281	0.000281	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000278	0.000278	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CD36—atherosclerosis	0.000276	0.000276	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	0.000275	0.000275	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	0.000275	0.000275	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	0.000275	0.000275	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SOCS3—atherosclerosis	0.000273	0.000273	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOB—atherosclerosis	0.000272	0.000272	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000272	0.000272	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	0.00027	0.00027	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	0.000268	0.000268	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	0.000266	0.000266	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—F2—atherosclerosis	0.000264	0.000264	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—VEGFA—atherosclerosis	0.000263	0.000263	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP3—atherosclerosis	0.000263	0.000263	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF2—atherosclerosis	0.000262	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MTHFR—atherosclerosis	0.000262	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LPL—atherosclerosis	0.00026	0.00026	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.00026	0.00026	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000258	0.000258	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HMOX1—atherosclerosis	0.000258	0.000258	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PPARA—atherosclerosis	0.000257	0.000257	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOB—atherosclerosis	0.000255	0.000255	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000253	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	0.000253	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000253	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CXCL8—atherosclerosis	0.000252	0.000252	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000252	0.000252	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EDN1—atherosclerosis	0.00025	0.00025	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—MAPK3—atherosclerosis	0.000249	0.000249	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AGT—atherosclerosis	0.000249	0.000249	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCL5—atherosclerosis	0.000249	0.000249	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOB—atherosclerosis	0.000247	0.000247	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	0.000246	0.000246	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	0.000245	0.000245	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOE—atherosclerosis	0.000244	0.000244	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LPL—atherosclerosis	0.000243	0.000243	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB1—atherosclerosis	0.000242	0.000242	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	0.000241	0.000241	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CAV1—atherosclerosis	0.000241	0.000241	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOA1—atherosclerosis	0.000241	0.000241	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTM1—atherosclerosis	0.00024	0.00024	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	0.00024	0.00024	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000238	0.000238	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PRKCG—atherosclerosis	0.000236	0.000236	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—LPL—atherosclerosis	0.000236	0.000236	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	0.000235	0.000235	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PLG—atherosclerosis	0.000234	0.000234	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GPX1—atherosclerosis	0.00023	0.00023	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.00023	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	0.00023	0.00023	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000229	0.000229	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	0.000229	0.000229	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	0.000228	0.000228	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CD36—atherosclerosis	0.000224	0.000224	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AGT—atherosclerosis	0.000223	0.000223	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000222	0.000222	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—AKT1—atherosclerosis	0.000222	0.000222	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	0.000221	0.000221	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000221	0.000221	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CG—atherosclerosis	0.00022	0.00022	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000219	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOE—atherosclerosis	0.000218	0.000218	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LEP—atherosclerosis	0.000218	0.000218	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.000217	0.000217	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	0.000216	0.000216	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	0.000216	0.000216	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	0.000214	0.000214	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	0.000213	0.000213	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	0.000213	0.000213	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MTHFR—atherosclerosis	0.000213	0.000213	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000212	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PPARG—atherosclerosis	0.000212	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARA—atherosclerosis	0.000209	0.000209	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	0.000208	0.000208	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—INS—atherosclerosis	0.000208	0.000208	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AGT—atherosclerosis	0.000208	0.000208	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—AKT1—atherosclerosis	0.000207	0.000207	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOB—atherosclerosis	0.000207	0.000207	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000207	0.000207	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—F2—atherosclerosis	0.000206	0.000206	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000205	0.000205	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LEP—atherosclerosis	0.000204	0.000204	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOE—atherosclerosis	0.000204	0.000204	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	0.000203	0.000203	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AGT—atherosclerosis	0.000202	0.000202	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	0.000202	0.000202	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	0.000202	0.000202	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	0.000201	0.000201	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.000201	0.000201	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.0002	0.0002	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOE—atherosclerosis	0.000198	0.000198	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LPL—atherosclerosis	0.000197	0.000197	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	0.000197	0.000197	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CAV1—atherosclerosis	0.000196	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOA1—atherosclerosis	0.000196	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	0.000194	0.000194	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—F2—atherosclerosis	0.000192	0.000192	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	0.000192	0.000192	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALB—atherosclerosis	0.000191	0.000191	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	0.000188	0.000188	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	0.000187	0.000187	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—INS—atherosclerosis	0.000186	0.000186	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.000186	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000186	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	0.000184	0.000184	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	0.000183	0.000183	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NOS3—atherosclerosis	0.000183	0.000183	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.000182	0.000182	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	0.00018	0.00018	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CG—atherosclerosis	0.000179	0.000179	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LEP—atherosclerosis	0.000178	0.000178	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOE—atherosclerosis	0.000178	0.000178	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	0.000176	0.000176	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	0.000176	0.000176	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	0.000176	0.000176	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—INS—atherosclerosis	0.000174	0.000174	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	0.000173	0.000173	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARG—atherosclerosis	0.000172	0.000172	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	0.000171	0.000171	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	0.000171	0.000171	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	0.00017	0.00017	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—INS—atherosclerosis	0.000169	0.000169	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AGT—atherosclerosis	0.000169	0.000169	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	0.000168	0.000168	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—AKT1—atherosclerosis	0.000168	0.000168	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—F2—atherosclerosis	0.000168	0.000168	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS2—atherosclerosis	0.000167	0.000167	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LEP—atherosclerosis	0.000165	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOE—atherosclerosis	0.000165	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	0.000164	0.000164	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	0.000164	0.000164	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	0.000163	0.000163	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000161	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	0.00016	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	0.000158	0.000158	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—F2—atherosclerosis	0.000156	0.000156	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALB—atherosclerosis	0.000155	0.000155	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	0.000154	0.000154	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	0.000153	0.000153	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—INS—atherosclerosis	0.000152	0.000152	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	0.00015	0.00015	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	0.000149	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NOS3—atherosclerosis	0.000148	0.000148	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	0.000147	0.000147	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	0.000145	0.000145	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	0.000143	0.000143	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INS—atherosclerosis	0.000141	0.000141	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	0.00014	0.00014	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	0.00014	0.00014	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	0.000139	0.000139	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	0.000138	0.000138	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	0.000137	0.000137	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS2—atherosclerosis	0.000136	0.000136	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	0.000135	0.000135	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	0.000133	0.000133	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	0.000131	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	0.000131	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	0.00013	0.00013	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	0.00013	0.00013	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	0.000129	0.000129	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	0.000124	0.000124	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	0.000121	0.000121	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	0.000119	0.000119	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	0.000119	0.000119	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	0.00011	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	0.00011	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	0.000108	0.000108	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	0.000107	0.000107	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	0.000106	0.000106	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	0.000106	0.000106	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	0.000105	0.000105	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	0.000104	0.000104	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	0.000104	0.000104	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	0.000104	0.000104	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	9.94e-05	9.94e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	9.84e-05	9.84e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	9.67e-05	9.67e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	9.65e-05	9.65e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	9.61e-05	9.61e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	9.52e-05	9.52e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	9.09e-05	9.09e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	8.93e-05	8.93e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	8.84e-05	8.84e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	8.82e-05	8.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	8.45e-05	8.45e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AKT1—atherosclerosis	8.39e-05	8.39e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	8.2e-05	8.2e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—atherosclerosis	8.14e-05	8.14e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—atherosclerosis	7.6e-05	7.6e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	7.51e-05	7.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	7.01e-05	7.01e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AKT1—atherosclerosis	6.81e-05	6.81e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—atherosclerosis	6.65e-05	6.65e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—atherosclerosis	6.18e-05	6.18e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	6.13e-05	6.13e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	5.7e-05	5.7e-05	CbGpPWpGaD
